UnknownNot applicableNCT06331117
Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies
Studying RASopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Principal Investigator
- Chiara Leoni, MD, PhDFondazione Policlinico A. Gemelli, IRCCS
- Intervention
- Diagnostic test(diagnostic_test)
- Enrollment
- 120 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Department of Woman and Child Health and Public Health, Fondazione Policlinico A. Gemelli, IRCCS, Roma, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06331117 on ClinicalTrials.govOther trials for RASopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07344480Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)Deutsches Herzzentrum Muenchen
- RECRUITINGNCT06776380Pubertal Development in Patients with RASopathiesIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGNCT06489067Study of the Thyroid Function and Echostructural Morphology in Patients Affected With Rasopathies (ECORAS2023)University of Bari Aldo Moro
- RECRUITINGNANCT05761314Solid Tumors in RASopathiesFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNCT04286360Hematological Anomalies in Children With RasopathyAssistance Publique - Hôpitaux de Paris